US.DHR · Danaher Corporation

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.5,
      "details": {
        "atrPct": 4.190956982803964,
        "turnoverUsdM": 1863.803707840485,
        "liquidityPoints": 0.8,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.DHR",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 182.3658,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 8.4,
      "take_profit_price": 216.2208,
      "target_multiplier": 1.9,
      "technical_strength": 1.63,
      "take_profit_percent": 8.6
    },
    "positionPoints": 1.5,
    "stopLossPoints": 1.2,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 8.381913965607929,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 86,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 59,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 27
  },
  "market": {
    "ma20": 195.1695,
    "ma50": 185.7788,
    "close": 199.05,
    "prevClose": 196.5,
    "avgVolume20": 6400750,
    "volumeRatio": 1.46,
    "changePercent": 1.3
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 27,
    "details": {
      "ret_5d": 0.11194910404848923,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 27,
      "vcp_bonus": 0,
      "vol_ratio": 1.5328130371437458,
      "ret_points": 16,
      "vol_points": 6,
      "range_ratio": 1.9908570633700802,
      "volat_points": 4,
      "day_range_pct": 0.057410247815972065,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 86,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.8,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 56,
        "contribution": 2.8
      },
      {
        "raw": 14,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 70,
        "contribution": 14
      },
      {
        "raw": 8.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 57.33,
        "contribution": 8.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.1,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 61,
        "contribution": 6.1
      },
      {
        "raw": 19.5,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 65,
        "contribution": 19.5
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 59,
    "details": [
      "基本面分析總分: 2.8/5分",
      "資金流分析總分: 14/20分",
      "市場環境分析總分: 8.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.1/10分",
      "技術信號分析總分: 19.5/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.8,
      "資金流": 14,
      "市場環境": 8.6,
      "情緒分析": 6,
      "技術信號": 19.5,
      "風險管理": 6.1
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0.4,
          "turnoverUsdM": 1863.803707840485,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "良好",
        "items": {
          "cmfPoints": 4,
          "mfiPoints": 3.2,
          "obvPoints": 1.6,
          "vwapPoints": 3.2,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.DHR",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 18.67
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 708.0634979000001,
                "ma50": 716.7494019999999,
                "name": "QQQ",
                "close": 675.48999,
                "points": 0.4
              },
              "spy": {
                "ma20": 746.6510067000002,
                "ma50": 744.8574021799999,
                "name": "SPY",
                "close": 740.85999,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 4.190956982803964,
          "atrPoints": 2,
          "cciPoints": 4,
          "vixPoints": 1.8,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 5,
              "sentimentScoreRaw": 1.5
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141019423,
                "url": "https://finnhub.io/api/news?id=ee3f0ec123d9828a3b1cd4bf0f09facdfaa7d97eb41c1f110c1b11ba81879492",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher (DHR) has attracted investor attention after issuing third quarter 2026 revenue guidance of 2% to 3% growth, alongside detailing recent share repurchases and releasing its latest quarterly earnings figures. See our latest analysis for Danaher. Despite Danaher's latest guidance, earnings update, and completion of multi year buyback programs, the stock has been under pressure in 2026, with the share price down 16.9% year to date and the 5 year total shareholder return also negative. If...",
                "category": "company",
                "datetime": 1785014128,
                "headline": "Danaher (DHR) Could Be 16% Undervalued On Earnings And 2026 Revenue Guidance"
              },
              {
                "id": 141015099,
                "url": "https://finnhub.io/api/news?id=5da501d9235c3d07078a38f1823e381919f915c24d37a4dfb0621e6f2ee3586b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher (NYSE:DHR) shares saw a sharp post earnings selloff, with heavy trading activity highlighting strong investor reaction. Following the drop, the stock closed near its daily highs, pointing to easing selling pressure and interest from buyers. The combination of intense volatility and late session stabilization has put Danaher back in focus for many shareholders. Danaher is a large science and technology company with businesses across diagnostics, life sciences, and environmental...",
                "category": "company",
                "datetime": 1784967126,
                "headline": "Danaher (DHR) Stock Tries To Steady After A Sharp Post Earnings Selloff"
              },
              {
                "id": 141005352,
                "url": "https://finnhub.io/api/news?id=4d73431f2c3617f58fa67a24b0853a1ef831c63ec81636bc814893cef053e08a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher's latest earnings call saw analysts repeatedly test one sore spot in an otherwise solid quarter, and management's answers reveal the key risk for investors now.",
                "category": "company",
                "datetime": 1784895812,
                "headline": "Reading Between The Lines Of DHR's Latest Call"
              },
              {
                "id": 140983180,
                "url": "https://finnhub.io/api/news?id=d16017ac7ea0040ec1174167f441678895a6cd22498fe852610f160ae8621811",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "The average of price targets set by Wall Street analysts indicates a potential upside of 32.4% in Danaher (DHR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.",
                "category": "company",
                "datetime": 1784728504,
                "headline": "Can Danaher (DHR) Climb 32.39% to Reach the Level Wall Street Analysts Expect?"
              },
              {
                "id": 140978464,
                "url": "https://finnhub.io/api/news?id=f75bae752910cbf34b6672bf6c2144446960401e8b524ad9b5776544605b43aa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Non-respiratory growth accelerated 150 basis points as life sciences recovered.",
                "category": "company",
                "datetime": 1784680212,
                "headline": "Danaher (DHR) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 140976462,
                "url": "https://finnhub.io/api/news?id=1cb3594a8c85fa2e6e68a1fb5e6b671d457337c4619254224d12a0c073d63681",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Shares of diversified science and technology company Danaher (NYSE:DHR) fell 13.3% in the morning session after it reported underwhelming second-quarter results. The negative reaction appeared to stem from underlying concerns about the company's profitability. While revenue grew 5.5% year over year to $6.27 billion and adjusted earnings per share of $1.94 beat estimates, the company's adjusted operating margin contracted significantly to 18%, a steep drop of 9.3 percentage points from the same q",
                "category": "company",
                "datetime": 1784665826,
                "headline": "Why Danaher (DHR) Shares Are Falling Today"
              },
              {
                "id": 140975011,
                "url": "https://finnhub.io/api/news?id=5b0da942987c21493369d7378b99849eaddabda4b1ccc72190b0adf9a44c979b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher Corp (DHR) reports robust Q2 performance with significant growth in Life Sciences and raises full-year EPS guidance, despite challenges in bioprocessing and developed markets.",
                "category": "company",
                "datetime": 1784660435,
                "headline": "Danaher Corp (DHR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Raised EPS Guidance"
              },
              {
                "id": 140971751,
                "url": "https://finnhub.io/api/news?id=7ab8a33c40f050d1cfe7a71f5acda21e8e5c0908b90ccd4bba585d85da16a318",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "The headline numbers for Danaher (DHR) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
                "category": "company",
                "datetime": 1784640603,
                "headline": "Compared to Estimates, Danaher (DHR) Q2 Earnings: A Look at Key Metrics"
              }
            ],
            "raw_source": [
              {
                "id": 141048349,
                "url": "https://finnhub.io/api/news?id=a1007d153ce0c9d685cf903a1f479f416a110b30f03142e61e661611eed2da45",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Water analytics and treatment company Veralto (NYSE:VLTO) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 7.5% year on year to $1.47 billion. Its non-GAAP profit of $1.11 per share was 10.3% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785275276,
                "headline": "Veralto’s (NYSE:VLTO) Q2 CY2026 Non-GAAP EPS Beat Estimates"
              },
              {
                "id": 141045284,
                "url": "https://finnhub.io/api/news?id=e230c03b4e1344ce98d6715be8d70854b2f51144a5c95c8a41454206af666ffb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Precision Diagnostics And Medicine Market size & share revenue was valued at approximately USD 147.23 Billion in 2025 and is expected to reach USD 159.66 Billion in 2026 and is expected to reach around USD 345.75 Billion by 2035, at a CAGR of 8.91% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are F. Hoff",
                "category": "company",
                "datetime": 1785259800,
                "headline": "[Latest] Global Precision Diagnostics And Medicine Market Size/Share Worth USD 345.75 Billion by 2035 at a 8.91% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)"
              },
              {
                "id": 141043102,
                "url": "https://finnhub.io/api/news?id=4def2ebd595d4441db1c358c20ea98221169d771dcb6942e98c2c7ed2cec1c4c",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "DHR",
                "summary": "Curious about the S&P500 stocks that are gapping on Tuesday? Explore the gap up and gap down stocks in the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1785249301,
                "headline": "These S&P500 stocks are gapping in today's session"
              },
              {
                "id": 141019423,
                "url": "https://finnhub.io/api/news?id=ee3f0ec123d9828a3b1cd4bf0f09facdfaa7d97eb41c1f110c1b11ba81879492",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher (DHR) has attracted investor attention after issuing third quarter 2026 revenue guidance of 2% to 3% growth, alongside detailing recent share repurchases and releasing its latest quarterly earnings figures. See our latest analysis for Danaher. Despite Danaher's latest guidance, earnings update, and completion of multi year buyback programs, the stock has been under pressure in 2026, with the share price down 16.9% year to date and the 5 year total shareholder return also negative. If...",
                "category": "company",
                "datetime": 1785014128,
                "headline": "Danaher (DHR) Could Be 16% Undervalued On Earnings And 2026 Revenue Guidance"
              },
              {
                "id": 141015099,
                "url": "https://finnhub.io/api/news?id=5da501d9235c3d07078a38f1823e381919f915c24d37a4dfb0621e6f2ee3586b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher (NYSE:DHR) shares saw a sharp post earnings selloff, with heavy trading activity highlighting strong investor reaction. Following the drop, the stock closed near its daily highs, pointing to easing selling pressure and interest from buyers. The combination of intense volatility and late session stabilization has put Danaher back in focus for many shareholders. Danaher is a large science and technology company with businesses across diagnostics, life sciences, and environmental...",
                "category": "company",
                "datetime": 1784967126,
                "headline": "Danaher (DHR) Stock Tries To Steady After A Sharp Post Earnings Selloff"
              },
              {
                "id": 141011008,
                "url": "https://finnhub.io/api/news?id=2b5681c8ad3445c10d7b6b93b6c6f3bb5e4d97717a3b68cc3433f7ac9b353349",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DHR",
                "summary": "Get the weekly dividend update for Champions, Contenders & Challengers—read about the dividend changes, upcoming ex-dividend dates and pay dates here.",
                "category": "company",
                "datetime": 1784916411,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of July 26"
              },
              {
                "id": 141006318,
                "url": "https://finnhub.io/api/news?id=bebd5c1d5fd38f186592359f3a85f1ed197c9092d7edc353ec1709f2fd264d58",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "The company delivered a mixed earnings report, but the sell-off looks like an overreaction.",
                "category": "company",
                "datetime": 1784903618,
                "headline": "Here's Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity"
              },
              {
                "id": 141010556,
                "url": "https://finnhub.io/api/news?id=756ebdb8b0c710884f696aad5c96d8654f10e655a244433181d5f8bc27e57f8c",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/24/West-Bangal--India---April-20--2022--Dan.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "Dan Loeb reduced his Danaher stake and exited Thermo Fisher in Q1 2026 as the billionaire investor trimmed life sciences exposure.",
                "category": "company",
                "datetime": 1784902999,
                "headline": "Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets"
              },
              {
                "id": 141006524,
                "url": "https://finnhub.io/api/news?id=32051c07b4e7a4e0c1418e8e01970f2ac0db8656ab65fcebe5b9d5274caa4129",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "EW beats Q2 earnings and revenue estimates as strong TAVR demand, and mitral and tricuspid therapy adoption lift results and guidance.",
                "category": "company",
                "datetime": 1784897640,
                "headline": "Edwards' Q2 Earnings & Revenues Top Estimates, Stock Rises"
              },
              {
                "id": 141005373,
                "url": "https://finnhub.io/api/news?id=b36b031e7ee377bc4138167b006d1828b02fd77c1e500f55b43a05f249614da2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Device makers with cash flow yields of 5% to 6% now trade at a 20% to 30% discount to the S&P 500 index.",
                "category": "company",
                "datetime": 1784895900,
                "headline": "6 Medical-Device Stocks to Buy After a Massive Selloff"
              },
              {
                "id": 141005352,
                "url": "https://finnhub.io/api/news?id=4d73431f2c3617f58fa67a24b0853a1ef831c63ec81636bc814893cef053e08a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher's latest earnings call saw analysts repeatedly test one sore spot in an otherwise solid quarter, and management's answers reveal the key risk for investors now.",
                "category": "company",
                "datetime": 1784895812,
                "headline": "Reading Between The Lines Of DHR's Latest Call"
              },
              {
                "id": 141003245,
                "url": "https://finnhub.io/api/news?id=2ebd8eda6820cc2c6f0a825f7bed40d44a97ae7a597344157a7a0eb81e98b72d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Device makers with cash flow yields of 5% to 6% now trade at a 20% to 30% discount to the S&P 500 index.",
                "category": "company",
                "datetime": 1784871000,
                "headline": "Medical-Device Stocks Are in the Bargain Bin. 6 to Buy."
              },
              {
                "id": 140997115,
                "url": "https://finnhub.io/api/news?id=2dc5c73f42c70ceb223c39789ca8fffdc01973a9abe48a2cfb8eb91f246ad1fc",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "DHR",
                "summary": "Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1784833500,
                "headline": "What's going on in today's session: S&P500 movers"
              },
              {
                "id": 140994690,
                "url": "https://finnhub.io/api/news?id=e8aaac5769731a4235ef98fb915fed6413b00f1b086d0d3b9c55985f925f7c3f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Biopharmaceutical production led applications in 2025, while sera, media and reagents dominated consumables. Asia-Pacific is expected to record the fastest growth through 2031. Key players include Thermo Fisher Scientific, Danaher, Sartorius, Merck and Corning. Cell Culture Market Cell Culture Market Dublin, July 23, 2026 (GLOBE NEWSWIRE) -- The \"Cell Culture Market by Consumables, Vessels, Equipment, Application, Competition - Global Forecast to 2031\" has been added to ResearchAndMarkets.com's",
                "category": "company",
                "datetime": 1784816280,
                "headline": "Cell Culture Market Analysis by Consumables, Vessels, Equipment, Application, and Competition - Global Forecast to 2031"
              },
              {
                "id": 140994723,
                "url": "https://finnhub.io/api/news?id=79fd17c84027588375b7e5a8a236ae382385fcb274c6606fa2b953d71a8ffca8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Thermo Fisher beats Q2 earnings and revenue estimates as organic growth and stronger customer activity lift results, sending shares higher in pre-market trading.",
                "category": "company",
                "datetime": 1784815260,
                "headline": "TMO Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-Market"
              },
              {
                "id": 140993403,
                "url": "https://finnhub.io/api/news?id=e58cc899e08165b58f4e4fafe85b36bdfa2028d5ca8c7b98f2599623e735a726",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Thermo Fisher stock led a medtech rebound Thursday, easing investors' fears of continued malaise for the medical research and tools realm.",
                "category": "company",
                "datetime": 1784814134,
                "headline": "The 'Standout Performance' That Could Save Thermo Fisher, Danaher And Others"
              },
              {
                "id": 140990928,
                "url": "https://finnhub.io/api/news?id=7ce44440fd0e70fe296a452703a01c496dfa5980d5edf6b9a14c7e4cb8e1b8d4",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2194222153/image_2194222153.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DHR",
                "summary": "The global food safety testing market is projected to grow from $28.1 billion in 2026 to $52.9 billion by 2034, driving structural growth for the HTEC index.",
                "category": "company",
                "datetime": 1784772300,
                "headline": "Cyclosporiasis: Investing In Biosecurity"
              },
              {
                "id": 140986194,
                "url": "https://finnhub.io/api/news?id=26ac5c70ade1dcc2b150e4fdd59c777f3abe258343b1d0a1eec44fe196037309",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "The ruling keeps a major patent judgment in place while a separate trade-secret dispute moves to appeal.",
                "category": "company",
                "datetime": 1784743925,
                "headline": "Apple Fails to Overturn $634 Million Masimo Verdict"
              },
              {
                "id": 140995388,
                "url": "https://finnhub.io/api/news?id=20fd03579656f8bd2bc6c4910bb5b49382c41be66d659d81dbce94728d3afc7e",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/22/Selloff-Could-Hit-Main-Street-Hard.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "Danaher Corporation (DHR) shares may have experienced a seller's capitulation. There has also been bullish action in the stock.",
                "category": "company",
                "datetime": 1784736575,
                "headline": "Stock Of The Day: Is The Danaher Selloff Over?"
              },
              {
                "id": 140983179,
                "url": "https://finnhub.io/api/news?id=f4a0b7158c72b174e5d9e0258f661b10d74d6e633c5c59fb4d50683cd969122f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher's (DHR) Q2 results were mixed, with the lumpier part of its bioprocess consumables business",
                "category": "company",
                "datetime": 1784734805,
                "headline": "Danaher Posts Mixed Q2 Results, Outlook for 2027 and Beyond Strengthened, RBC Says"
              },
              {
                "id": 140995389,
                "url": "https://finnhub.io/api/news?id=0c065d7615fa5ef116b63b023119a233cdb69887d95b24ceb3f822cdfb1bbf2d",
                "image": "",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "Wells Fargo  analyst Brandon Couillard   maintains Danaher (NYSE:DHR) with a Equal-Weight and lowers the price target from $212 to $195.",
                "category": "company",
                "datetime": 1784732447,
                "headline": "Wells Fargo Maintains Equal-Weight on Danaher, Lowers Price Target to $195"
              },
              {
                "id": 140983180,
                "url": "https://finnhub.io/api/news?id=d16017ac7ea0040ec1174167f441678895a6cd22498fe852610f160ae8621811",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "The average of price targets set by Wall Street analysts indicates a potential upside of 32.4% in Danaher (DHR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.",
                "category": "company",
                "datetime": 1784728504,
                "headline": "Can Danaher (DHR) Climb 32.39% to Reach the Level Wall Street Analysts Expect?"
              },
              {
                "id": 140995390,
                "url": "https://finnhub.io/api/news?id=62117fee2e4d83c504b230ab1f98b41da2903c04aeba32e73b4226b862f25c1e",
                "image": "",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "TD Cowen  analyst Dan Brennan   maintains Danaher (NYSE:DHR) with a Buy and lowers the price target from $240 to $236.",
                "category": "company",
                "datetime": 1784728378,
                "headline": "TD Cowen Maintains Buy on Danaher, Lowers Price Target to $236"
              },
              {
                "id": 140981673,
                "url": "https://finnhub.io/api/news?id=eb46a5e34641428add077553c4238dc647d4d35d742ba507b318d0f94fcf7c79",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Apple Loses Key Court Bid in $634 Million Apple Watch Blood Oxygen Dispute",
                "category": "company",
                "datetime": 1784725911,
                "headline": "Apple Stumbles in Court as $634 Million Apple Watch Judgment Survives"
              },
              {
                "id": 140995391,
                "url": "https://finnhub.io/api/news?id=44382a4006052c43103f7da80b109ae5c0754661ee8acafdc66be983b5cc691f",
                "image": "",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "Stifel  analyst Daniel Arias   maintains Danaher (NYSE:DHR) with a Buy and lowers the price target from $260 to $220.",
                "category": "company",
                "datetime": 1784725003,
                "headline": "Stifel Maintains Buy on Danaher, Lowers Price Target to $220"
              },
              {
                "id": 140995392,
                "url": "https://finnhub.io/api/news?id=e122d2ce5cbea2aeb595b9a915b013eb0346dc55b0306a0f2405b9b9700169d6",
                "image": "",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "Guggenheim  analyst Subbu Nambi   maintains Danaher (NYSE:DHR) with a Buy and lowers the price target from $235 to $200.",
                "category": "company",
                "datetime": 1784723509,
                "headline": "Guggenheim Maintains Buy on Danaher, Lowers Price Target to $200"
              },
              {
                "id": 140983625,
                "url": "https://finnhub.io/api/news?id=bf1a3da18b29464158c2918ba993f0c4f7bf2f872744c4b99591a103415cd15a",
                "image": "",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "RBC Capital  analyst Dan Leonard   maintains Danaher (NYSE:DHR) with a Outperform and raises the price target from $200 to $215.",
                "category": "company",
                "datetime": 1784717585,
                "headline": "RBC Capital Maintains Outperform on Danaher, Raises Price Target to $215"
              },
              {
                "id": 140980349,
                "url": "https://finnhub.io/api/news?id=79b87c4f6a95276bf57a5faf3e8d5bd8b9ec55cc80c8a0c83a330d7b3503726d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "To say  Danaher Corp.  had a downbeat reaction to earnings is an understatement.  Danaher had its worst day in two decades on Tuesday after the life sciences and diagnostics company’s second-quarter earnings.  Danaher expects core revenue (a metric that excludes things like currency and acquisitions) to increase between 2% and 3% for the third quarter, and Danaher narrowed its full-year forecast to 3% to 4% growth from the prior 3% to 6% expectation.",
                "category": "company",
                "datetime": 1784711160,
                "headline": "Don’t Quit on Danaher Stock After Horrific Earnings Reaction"
              },
              {
                "id": 140980350,
                "url": "https://finnhub.io/api/news?id=d004088c0e57dfa3e79ad9a9cb5e8301e2cee05e313cf77ea59ca3b70e2b8813",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "The Morning Bull - US Market Morning Update Wednesday, Jul, 22 2026 US stock futures are pointing higher, with key contracts linked to the S&P 500 up about 0.5% and Nasdaq 100 futures up roughly 1.3%, as investors weigh fresh inflation worries against easing rate fears abroad. In the US, the 10 year Treasury yield sits near 4.6%, and markets see roughly a 50 to 60% chance of a Federal Reserve rate hike in September, which matters for mortgage costs, credit cards and growth focused stocks. At...",
                "category": "company",
                "datetime": 1784707813,
                "headline": "US Stock Market Today S&P 500 Futures Rise On Earnings And Inflation Crosscurrents"
              },
              {
                "id": 140978464,
                "url": "https://finnhub.io/api/news?id=f75bae752910cbf34b6672bf6c2144446960401e8b524ad9b5776544605b43aa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Non-respiratory growth accelerated 150 basis points as life sciences recovered.",
                "category": "company",
                "datetime": 1784680212,
                "headline": "Danaher (DHR) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 140976462,
                "url": "https://finnhub.io/api/news?id=1cb3594a8c85fa2e6e68a1fb5e6b671d457337c4619254224d12a0c073d63681",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Shares of diversified science and technology company Danaher (NYSE:DHR) fell 13.3% in the morning session after it reported underwhelming second-quarter results. The negative reaction appeared to stem from underlying concerns about the company's profitability. While revenue grew 5.5% year over year to $6.27 billion and adjusted earnings per share of $1.94 beat estimates, the company's adjusted operating margin contracted significantly to 18%, a steep drop of 9.3 percentage points from the same q",
                "category": "company",
                "datetime": 1784665826,
                "headline": "Why Danaher (DHR) Shares Are Falling Today"
              },
              {
                "id": 140976272,
                "url": "https://finnhub.io/api/news?id=9d7b389bf5044e1eb5c384b89a4616b8ce174241e10a650c3ed766231ee40e6b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "(Updates with market moves at the end of the day.) US equities advanced Tuesday after a three-day",
                "category": "company",
                "datetime": 1784665814,
                "headline": "Update: Wall Street Snaps 3-Day Losing Streak in Tech-Led Bounce"
              },
              {
                "id": 140976464,
                "url": "https://finnhub.io/api/news?id=06f0501582edabc25ab85d0eb77c8b6fb4d2a976d5eca21d77898b9373845fab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "US equity indexes ended higher on Tuesday as semiconductor stocks led gains in the technology sector",
                "category": "company",
                "datetime": 1784664635,
                "headline": "US Equity Markets Close Higher as Chipmakers Lead Tech Gains"
              },
              {
                "id": 140974895,
                "url": "https://finnhub.io/api/news?id=1ac5caa10a21ca147aa3006cba72e0bc0f153d7e70b3a4dc4eb91f33349c26f2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Healthcare stocks advanced late Tuesday afternoon with the NYSE Healthcare Index rising 0.6% and the",
                "category": "company",
                "datetime": 1784662859,
                "headline": "Sector Update: Healthcare Stocks Rise Late Afternoon"
              },
              {
                "id": 140974412,
                "url": "https://finnhub.io/api/news?id=2dd1c2451b03575b1d24ea44706c11d8d102cb4c6edda3db010580bb502a04cc",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "DHR",
                "summary": "Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday.",
                "category": "company",
                "datetime": 1784660700,
                "headline": "Uncover the latest developments among S&P500 stocks in today's session."
              },
              {
                "id": 140975010,
                "url": "https://finnhub.io/api/news?id=4f5c31ae77b2b7d782f42e0783177ad846caeb01f8c933edd8b58758681452a1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Shares of biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) fell 7% in the morning session after investors reacted to the company's weak full-year guidance ahead of its upcoming earnings report, alongside concerns over project delays highlighted by industry peer Danaher. The cautious outlook amplified bearish sentiment before Repligen's second-quarter results, expected on July 28. The guidance signaled expectations for slower growth and tougher near-term conditions. Adding to th",
                "category": "company",
                "datetime": 1784660546,
                "headline": "Why Repligen (RGEN) Stock Is Trading Lower Today"
              },
              {
                "id": 140975011,
                "url": "https://finnhub.io/api/news?id=5b0da942987c21493369d7378b99849eaddabda4b1ccc72190b0adf9a44c979b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher Corp (DHR) reports robust Q2 performance with significant growth in Life Sciences and raises full-year EPS guidance, despite challenges in bioprocessing and developed markets.",
                "category": "company",
                "datetime": 1784660435,
                "headline": "Danaher Corp (DHR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Raised EPS Guidance"
              },
              {
                "id": 140973253,
                "url": "https://finnhub.io/api/news?id=bd19357f6fefe41796eb9b0c92f522b07294f91607e9ffb4d083287023ccf230",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "The AI trade is back as investors shrug off fears about a slew of cheap Chinese large-language models.",
                "category": "company",
                "datetime": 1784657580,
                "headline": "SpaceX, Micron, Western Digital, Coinbase, Danaher, and More Stocks That Explain Today’s Market"
              },
              {
                "id": 140984212,
                "url": "https://finnhub.io/api/news?id=7cce8cd74f43aa5032bc84f84f68f84b9b1b5cbb7a8621dde485f82025fc9d5d",
                "image": "https://image.cnbcfm.com/api/v1/image/108338187-17846708261784670823-47307997091-1080pnbcnews.jpg?v=1784670825&w=1920&h=1080",
                "source": "CNBC",
                "related": "DHR",
                "summary": "Mizuho's Jared Holz joins 'Fast Money' to talk Danaher stock selling off on revenue outlook.",
                "category": "company",
                "datetime": 1784656669,
                "headline": "Mizuho's Jared Holz talks Danaher seeing its worst trading day in 25 years"
              },
              {
                "id": 140973158,
                "url": "https://finnhub.io/api/news?id=d9971ce22c8016bf00f1d83018407a5193f78f2bda2658b4725372f4faec1cb9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "(Updates with latest market prices and developments.) US benchmark equity indexes were higher int",
                "category": "company",
                "datetime": 1784656379,
                "headline": "Update: Equity Markets Rise Intraday in Tech-Led Advance"
              },
              {
                "id": 140973254,
                "url": "https://finnhub.io/api/news?id=7cca9487422533579c49e732eec72b53588140d7206136df59fb6cb6c55fb443",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Healthcare stocks were higher Tuesday afternoon, with the NYSE Healthcare Index rising 0.4% and the",
                "category": "company",
                "datetime": 1784654979,
                "headline": "Sector Update: Healthcare Stocks Advance Tuesday Afternoon"
              },
              {
                "id": 140972746,
                "url": "https://finnhub.io/api/news?id=83d0f86dc3c9e0a6cefc3d541632d89f8454c19eaf69aa5f4216047ca888b270",
                "image": "https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp",
                "source": "ChartMill",
                "related": "DHR",
                "summary": "Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.",
                "category": "company",
                "datetime": 1784653500,
                "headline": "Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below."
              },
              {
                "id": 140972632,
                "url": "https://finnhub.io/api/news?id=209824d93f8b21c9169df13ab65a7d4fc6af4abe9f52c14fa1824d96a8ea2fff",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "DHR",
                "summary": "Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.",
                "category": "company",
                "datetime": 1784651701,
                "headline": "Explore the top gainers and losers within the S&P500 index in today's session."
              },
              {
                "id": 140971564,
                "url": "https://finnhub.io/api/news?id=1bf4a57be3dd22914964e340811aa40d739283a736d914beccd336aa57b7e604",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "All three major US stock indexes were up in late-morning trading Tuesday, as investors focused on so",
                "category": "company",
                "datetime": 1784648948,
                "headline": "Top Midday Stories: 3M Shares Rise on Strong Guidance; Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising"
              },
              {
                "id": 140973415,
                "url": "https://finnhub.io/api/news?id=0bd242c66006a6bff3ef5c4ed8e2fa59aa85dcc5cf5257c89b974529dd6b6ca8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "DHR beats Q2 estimates as Life Sciences posts its strongest quarter in years, prompting the company to raise its 2026 adjusted EPS outlook.",
                "category": "company",
                "datetime": 1784648040,
                "headline": "Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y"
              },
              {
                "id": 140971117,
                "url": "https://finnhub.io/api/news?id=d766533089a9bceedc73f0a39f86785bbc2c007536630cb10915aad48690833f",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "DHR",
                "summary": "Let's have a look at the S&P500 gap up and gap down stocks in today's session.",
                "category": "company",
                "datetime": 1784644501,
                "headline": "Gapping S&P500 stocks in Tuesday's session"
              },
              {
                "id": 140971748,
                "url": "https://finnhub.io/api/news?id=3b0c03bff67dba50d09330d37f46bdee5bffd0a7d32c77b16b38adc6a2558e11",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher raised its full-year profit guidance on Tuesday as its fiscal second-quarter results came in",
                "category": "company",
                "datetime": 1784644360,
                "headline": "Danaher Lifts Full-Year Profit Outlook Following Second-Quarter Beat, Tempers Sales Guidance"
              },
              {
                "id": 140971749,
                "url": "https://finnhub.io/api/news?id=60c0683778dcbc79b5b119366e715c33e5734de53ee2e0750d0a5ef981e6d2ca",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher posts better-than-expected earnings, but its core revenue forecast disappoints and send shares tumbling.",
                "category": "company",
                "datetime": 1784644140,
                "headline": "Behind Danaher’s Worst Stock Selloff in Over 30 Years"
              },
              {
                "id": 140974516,
                "url": "https://finnhub.io/api/news?id=8dcb7905f47cb5295ad9434a48de643ceff42ec8f007a5cca6fda35426b2b1ba",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/21/Oil-Trend-Up--Crude-Oil-Price-Stock-Exch.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "US stocks trade higher as Dow Jones gains over 350 points. Tech shares rise by 2% while consumer staples fall. 3M Co. sees 9% jump after strong earnings.",
                "category": "company",
                "datetime": 1784643492,
                "headline": "Crude Oil Surges 2%; 3M Shares Gain After Q2 Results"
              },
              {
                "id": 140971750,
                "url": "https://finnhub.io/api/news?id=d3a1cfe6576151bb68c0787aad3476cdb5fb8a76a03e7ab04de96a112432750c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher (NYSE:DHR) reported better-than-expected second-quarter 2026 results, with management citing accelerating core revenue growth, stronger life sciences demand and benefits from productivity initiatives, while also addressing investor concerns over delayed bioprocessing shipments. President an",
                "category": "company",
                "datetime": 1784642810,
                "headline": "Danaher Q2 Earnings Call Highlights"
              },
              {
                "id": 140973830,
                "url": "https://finnhub.io/api/news?id=1e57210f67d18b1adf29dc25258d8a02caadfc067a066d923fb660ce26c96c35",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/21/Los-Angeles--California---24-January-202.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "Semiconductors led a broad rebound Tuesday as Micron, Western Digital and Sandisk surged. Nasdaq 100 rallies past 29,000 points.",
                "category": "company",
                "datetime": 1784641208,
                "headline": "Micron Leads Memory-Stock Rally, Nasdaq 100 Tops 29,000: Stock Market Today"
              },
              {
                "id": 140971751,
                "url": "https://finnhub.io/api/news?id=7ab8a33c40f050d1cfe7a71f5acda21e8e5c0908b90ccd4bba585d85da16a318",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "The headline numbers for Danaher (DHR) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
                "category": "company",
                "datetime": 1784640603,
                "headline": "Compared to Estimates, Danaher (DHR) Q2 Earnings: A Look at Key Metrics"
              },
              {
                "id": 140970565,
                "url": "https://finnhub.io/api/news?id=077c26f7181f7d450a43c975be868b63aa2f574dc4b54a2d532ed12ec114c02f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher stock plummeted Tuesday after reporting what one analyst called \"surprisingly soft\" bioprocessing sales.",
                "category": "company",
                "datetime": 1784639166,
                "headline": "Danaher Plummets After One Segment Comes In 'Surprisingly Soft'"
              },
              {
                "id": 140970414,
                "url": "https://finnhub.io/api/news?id=98215c68bd9a43028547434e5658251983f061c663d7e8bc0a47ed9a5786f061",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "(Updates with economic data, recent oil price movement, world markets' overview and corporate stock",
                "category": "company",
                "datetime": 1784638216,
                "headline": "Update: Potential Middle East Ceasefire Lifts US Equity Futures Pre-Bell"
              },
              {
                "id": 140969915,
                "url": "https://finnhub.io/api/news?id=aa72a66fb0d5bcf6c69aa9f3f299297ef27ee139d66ed757cdf8742165005e2a",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "DHR",
                "summary": "Discover the top S&P500 movers in Tuesday's pre-market session and stay informed about market dynamics.",
                "category": "company",
                "datetime": 1784637300,
                "headline": "Get insights into the top movers in the S&P500 index of Tuesday's pre-market session."
              },
              {
                "id": 140972391,
                "url": "https://finnhub.io/api/news?id=87ca54fdd03e4c6d65dfca8a436be6887fb09553b5209554d182ef85fa70ba95",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157258075/image_2157258075.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DHR",
                "summary": "Danaher delivered Q2 revenue of $6.3B, beating estimates and segment growth across Biotechnology, Diagnostics, and Life Sciences. Read more on DHR stock here.",
                "category": "company",
                "datetime": 1784636416,
                "headline": "Danaher Q2 Earnings Review: Nothing Exciting For Me To Buy This Dip"
              },
              {
                "id": 140972088,
                "url": "https://finnhub.io/api/news?id=149fe5fca56474bdb9b23159a55e9c963dae401fb31e1848cc14b43afc1bb328",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "DHR",
                "summary": "Danaher Corporation (DHR) Q2 2026 Earnings Call July 21, 2026 8:00 AM EDTCompany ParticipantsRachel Vatnsdal Olson - Vice President of Investor...",
                "category": "company",
                "datetime": 1784635439,
                "headline": "Danaher Corporation (DHR) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 140969524,
                "url": "https://finnhub.io/api/news?id=e78e112b32fb6c3c464a652f3e5690b3203fac1ad8ab1ae0472844f24aaa2ce0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "US equity futures were tracking in the green on Tuesday as traders await the latest batch of corpora",
                "category": "company",
                "datetime": 1784634487,
                "headline": "Stocks Rise Pre-Bell as Investors Await More Earnings, Monitor Middle East Developments"
              },
              {
                "id": 140969544,
                "url": "https://finnhub.io/api/news?id=26c7539781fdb4a0d6d09c8f2251294ac491043b71b91466a5e2a6e482a07dda",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Strong quarterly performance overshadowed by softer near-term outlookDanaher Corporation (NYSE:DHR) reported second-quarter results that exceeded Wall Street expectations, but investors focused on a more cautious growth outlook for the current quarter, sending the shares down 9% in pre-market trading. The life sciences and diagnostics company posted adjusted earnings per share of $1.",
                "category": "company",
                "datetime": 1784632590,
                "headline": "Danaher shares slide despite second-quarter earnings and revenue beat (DHR)"
              },
              {
                "id": 140970567,
                "url": "https://finnhub.io/api/news?id=e18e5ab89e62d34453885ec75422f065d2a4ceaa01eebc75e0d9f0870b89297b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher (DHR) delivered earnings and revenue surprises of +5.44% and +2.88%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1784632501,
                "headline": "Danaher (DHR) Q2 Earnings and Revenues Top Estimates"
              },
              {
                "id": 140969545,
                "url": "https://finnhub.io/api/news?id=6cc7bcbcf5d38d16a4f36987b19fb382297bb3533c2c4513a0f898227a588ba5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Wall Street futures pointed higher pre-bell Tuesday as tech traders toggled risk-on switches despite",
                "category": "company",
                "datetime": 1784632213,
                "headline": "Tech Rebound Boosts Wall Street Pre-Bell; Asia, Europe Up"
              },
              {
                "id": 140969546,
                "url": "https://finnhub.io/api/news?id=5bc4fff15c933538346b91a0462e0c49679ec96fcd61fc1e48f22081125b077f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Investing.com -- Danaher Corporation (NYSE:DHR) reported second quarter results that exceeded analyst expectations, but shares fell 9% premarket.",
                "category": "company",
                "datetime": 1784630972,
                "headline": "Danaher shares tumble despite earnings beat"
              },
              {
                "id": 140969547,
                "url": "https://finnhub.io/api/news?id=a45480b686709e95af1f11d635f628d2ee599ac95db3872312b53437726b972c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Diversified science and technology company Danaher (NYSE:DHR) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 5.5% year on year to $6.27 billion. Its non-GAAP profit of $1.94 per share was 4.9% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1784629422,
                "headline": "Danaher (NYSE:DHR) Posts Better-Than-Expected Sales In Q2 CY2026 But Stock Drops"
              },
              {
                "id": 140973831,
                "url": "https://finnhub.io/api/news?id=f1918dbc6fd1c69cc732a5780e8441092a1d32d1ea5b76d85793fd993b3f6ca4",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/21/West-Bangal--India---April-20--2022--Dan.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "Danaher stock plunges despite Q2 earnings beat as the company cuts its 2026 core revenue growth forecast. Read details.",
                "category": "company",
                "datetime": 1784628775,
                "headline": "Why Danaher Stock Just Tanked 14%"
              },
              {
                "id": 140969548,
                "url": "https://finnhub.io/api/news?id=8ac817dae36a07f4b02ee8634f2f0f74eabde947c07a43684063567a0a07fd2c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher Corporation (NYSE: DHR) today announced results for the second quarter 2026. All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted.",
                "category": "company",
                "datetime": 1784628000,
                "headline": "Danaher Reports Second Quarter 2026 Results"
              },
              {
                "id": 140973832,
                "url": "https://finnhub.io/api/news?id=3925779b489aaa6103fe265c31f3f921a8d59d6277ba6b1284e3af04ac9b0839",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "Danaher (NYSE:DHR) released second-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below.\nBenzinga APIs provide real-time access to earnings call transcripts and financial",
                "category": "company",
                "datetime": 1784626579,
                "headline": "Transcript: Danaher Q2 2026 Earnings Conference Call"
              },
              {
                "id": 140969886,
                "url": "https://finnhub.io/api/news?id=52b55d5c26522e5ac42c60371ff7c0d6f14115af608a80985c26e1f7be038b32",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "DHR",
                "summary": "2026-07-21. The following slide deck was published by Danaher Corporation in conjunction with their 2026 Q2 earnings call.",
                "category": "company",
                "datetime": 1784622647,
                "headline": "Danaher Corporation 2026 Q2 - Results - Earnings Call Presentation"
              },
              {
                "id": 140970909,
                "url": "https://finnhub.io/api/news?id=6a0f14ba92c874e3ab73aafa68a0c310e7b9df25e1e943b42ca2422a07f71008",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/21/West-Bangal--India---April-20--2022--Dan.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "US stock futures up, Nasdaq 100 gains 1%. Danaher Corp (DHR) shares fall 10.1% in pre-market trading. Other stocks also decline.",
                "category": "company",
                "datetime": 1784620865,
                "headline": "Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session"
              },
              {
                "id": 140970908,
                "url": "https://finnhub.io/api/news?id=0bde65e53e00b2bc3f65bfc70ab4d00871a73169ccd8210a758296678bd36b88",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/earnings_scheduled_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "Companies Reporting Before The Bell\n• Mueller Industries (NYSE:MLI) is projected to report quarterly earnings at $1.15 per share on revenue of $1.27 billion. \n• Valmont Industries (NYSE:VMI) is projected to report",
                "category": "company",
                "datetime": 1784617872,
                "headline": "Earnings Scheduled For July 21, 2026"
              },
              {
                "id": 140973835,
                "url": "https://finnhub.io/api/news?id=06d00b96bc21090099f4377181b1e700e63b26a6021b2bc87ebe057a3aae3590",
                "image": "",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "Danaher (NYSE:DHR) raises FY2026 Adj EPS guidance from $8.35-$8.55 to $8.45-$8.60 vs $8.45 analyst estimate..",
                "category": "company",
                "datetime": 1784613684,
                "headline": "Danaher Raises FY2026 Adj EPS Guidance from $8.35-$8.55 to $8.45-$8.60 vs $8.45 Est"
              },
              {
                "id": 140963655,
                "url": "https://finnhub.io/api/news?id=8e8a9bc177421c2262200b6f5b61cb3b7f17f1eaaca89b5b57203bb3162d8613",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/20/Bullish-Posts-Strong-Earnings.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "Earnings are back in focus on Tuesday, with a Benzinga-selected slate including Danaher Corp. (NYSE:DHR). Options pricing reveals traders are bracing for volatility, with Annaly Capital Management (NYSE:NLY) and The Charles Schwab Corp. (NYSE:SCHW) reporting. Both stocks have seen positive analyst ratings and are trading above their 200-day moving averages.",
                "category": "company",
                "datetime": 1784561377,
                "headline": "Danaher Could Swing Over $7 Billion in Value After Earnings"
              },
              {
                "id": 140960535,
                "url": "https://finnhub.io/api/news?id=4a0c9cdc7347cf4f089f87cb71009406c597f7cc3ce3edf6c054e79446110d73",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Wall Street heads into a pivotal week with investors preparing for a flood of corporate earnings, major artificial intelligence announcements and lingering geopolitical tensions that have pushed oil prices above $90 a barrel. The spotlight will be on Wednesday's earnings from Alphabet Inc...",
                "category": "company",
                "datetime": 1784558760,
                "headline": "Week ahead: Wall Street gears up for volatility as Big Tech earnings kick into high gear"
              },
              {
                "id": 140959628,
                "url": "https://finnhub.io/api/news?id=a02e69e3e5e25c25f43ad23e6bf60542d3a84db9da3b59b69daa776dabca02dd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.",
                "category": "company",
                "datetime": 1784554533,
                "headline": "3 Cash-Producing Stocks with Warning Signs"
              },
              {
                "id": 140958662,
                "url": "https://finnhub.io/api/news?id=3cbe5c2fb994164c044959c3e71b3ff33b531f3586b7a8cf7244dafd5e7105c2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Wall Street is coming into a busy week of earnings with high expectations.",
                "category": "company",
                "datetime": 1784548404,
                "headline": "Earnings live: Google, Tesla to kick off 'Magnificent Seven' quarterly results"
              },
              {
                "id": 140960936,
                "url": "https://finnhub.io/api/news?id=2c6b8b58a31f7aa66f8aa3b6773013169c86931d70da3969996fe4c331038e24",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/20/Quarterly-Results-Sales-Profits-Earnings.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "Earnings season takes center stage next week with options markets pricing in big post-results moves. Benzinga selected top stocks to watch.",
                "category": "company",
                "datetime": 1784543345,
                "headline": "Intel Could Swing $61.4 Billion in Value After Earnings This Week"
              },
              {
                "id": 140957168,
                "url": "https://finnhub.io/api/news?id=b1383772ddecb80d86a0cd3aefcdf94254b6db530b6aa24a312aac5787222e26",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Diversified science and technology company Danaher (NYSE:DHR) will be reporting results this Tuesday before market hours. Here’s what you need to know.",
                "category": "company",
                "datetime": 1784524150,
                "headline": "Danaher (DHR) Q2 Earnings Report Preview: What To Look For"
              },
              {
                "id": 140951393,
                "url": "https://finnhub.io/api/news?id=aa6674b923f5dd3997e414963f20d36f2a01175a7747127b41d946914efb4677",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/186805810/image_186805810.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DHR",
                "summary": "Dan Loeb’s Third Point 13F: portfolio slashed to $2.08B, big AMZN stake, exits like MSFT, new META/GOOGL buys.",
                "category": "company",
                "datetime": 1784450913,
                "headline": "Tracking Dan Loeb's Third Point Portfolio - Q1 2026 Update"
              },
              {
                "id": 140939163,
                "url": "https://finnhub.io/api/news?id=2b7e563ff687d8cc979d3783bccd33f2bf9feb60d528dbd963b372e93e4735fb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "The healthcare giant's stock jump was about more than an earnings beat, offering proof of a growth story broader and more resilient than you thought.",
                "category": "company",
                "datetime": 1784328964,
                "headline": "Abbott Just Showed Its Growth Engine Has More Than One Cylinder"
              },
              {
                "id": 140933104,
                "url": "https://finnhub.io/api/news?id=40e9d7002eab4004d0bb87377bc6eff91abe0004872c0056185cab071cebb894",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Interactive Brokers leads Zacks' featured research, with reports also spotlighting Danaher, S&P Global and Optical Cable's growth drivers and risks.",
                "category": "company",
                "datetime": 1784294700,
                "headline": "The Zacks Analyst Blog Highlights Interactive Brokers, Danaher, S&P Global and Optical Cable"
              },
              {
                "id": 140931563,
                "url": "https://finnhub.io/api/news?id=9a8cdb541c3ef9be788480458508c8b7afe3ea54b0f0964b1a39fcf2f3561dab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "This healthcare giant is forecasting a significant acceleration, but you are being asked to look past a slowdown in its biggest growth engine and other execution hurdles.",
                "category": "company",
                "datetime": 1784290654,
                "headline": "Can Abbott Stock Deliver on Its Second-Half Growth Promise?"
              },
              {
                "id": 140930833,
                "url": "https://finnhub.io/api/news?id=f7f5d7bdf196729ba552af92a464ef85d6921b4b439e2d648be78749a5dd7417",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Leica Biosystems, part of Danaher, has entered a definitive agreement to acquire StatLab Medical Products. The deal expands Danaher's diagnostics and anatomical pathology offering and adds more consumables and instruments to its portfolio. This development is relevant for investors tracking NYSE:DHR, as it focuses attention on the diagnostics segment. Danaher, traded as NYSE:DHR, is leaning further into diagnostics through Leica Biosystems' planned acquisition of StatLab Medical Products...",
                "category": "company",
                "datetime": 1784286743,
                "headline": "Danaher (DHR) Is Expanding Diagnostics With A StatLab Medical Products Deal"
              },
              {
                "id": 140929128,
                "url": "https://finnhub.io/api/news?id=ce8d49c148b3b8c37755896a219d237007309e246076cb3470fb82f5561a494e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher stock presents a clear valuation tension right now, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while the earnings based multiples suggest the shares are already pricing in a premium. Over the past 5 years, Danaher shareholders have seen the stock decline about 18%, which frames the current valuation debate against a weaker long term return profile. Recent news around portfolio moves in diagnostics and pathology can support expectations...",
                "category": "company",
                "datetime": 1784264942,
                "headline": "Danaher (DHR) Stock May Trade At A Discount Despite Its 18% Five Year Decline"
              },
              {
                "id": 140929857,
                "url": "https://finnhub.io/api/news?id=5af17e559239cdd6954f090d6fa62bc90457aa54e7e1e7839f252f9aac4683c5",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1150663437/image_1150663437.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DHR",
                "summary": "Read here for an update on Barron’s 2026 dividend “dogcatcher” picks—safer high-yield stocks, projected gains to 2027, and free-cash-flow red flags.",
                "category": "company",
                "datetime": 1784264407,
                "headline": "2 DiviDog Buys By Barron's Mid-Year Round Table Pros"
              },
              {
                "id": 140928691,
                "url": "https://finnhub.io/api/news?id=0034d5256249c3c8762c2f9702eddef42e000a76b97af27dc4f1cd1837c2546a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher, which released its Q2 2026 results on 21 July, saw expectations firm up ahead of the report as analysts projected modest year-on-year growth in revenue and earnings, helped by solid bioprocessing demand, improved filtration activity, and contributions from the Masimo acquisition despite cost pressures and higher debt. Investors are focusing on how Masimo’s integration and continued strength in bioprocessing and diagnostics could offset weaker areas like Diagnostics and rising input,...",
                "category": "company",
                "datetime": 1784254452,
                "headline": "Can Masimo’s Integration and Bioprocessing Strength Reshape Danaher’s Long-Term Story (DHR)?"
              },
              {
                "id": 140927426,
                "url": "https://finnhub.io/api/news?id=78f11e4d4ffab8459cdc11b68842883243b41924b7a0953459ff8b2a758f39e8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Interactive Brokers, Danaher and S&P Global lead today's featured research, highlighting key growth drivers, challenges and performance trends.",
                "category": "company",
                "datetime": 1784237940,
                "headline": "Top Research Reports for Interactive Brokers, Danaher & S&P Global"
              },
              {
                "id": 140922770,
                "url": "https://finnhub.io/api/news?id=6c2da72828565fe47d4f12d7054c87e5c4c0a990028256d5cfa749490a4ce677",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
                "category": "company",
                "datetime": 1784218204,
                "headline": "Will Danaher (DHR) Beat Estimates Again in Its Next Earnings Report?"
              },
              {
                "id": 140922763,
                "url": "https://finnhub.io/api/news?id=dc4955263ecd30f9602dfc000f5bacd34f86464174631084d5e636d601f094f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "DHR heads into Q2 earnings with bioprocessing and diagnostics strength, but rising costs and debt could pressure profitability.",
                "category": "company",
                "datetime": 1784216760,
                "headline": "Danaher Gears Up to Post Q2 Earnings: Is a Beat in the Offing?"
              },
              {
                "id": 140921108,
                "url": "https://finnhub.io/api/news?id=3b7a3c592c254f9582eda27e64ea6f8fc5853218c696d9e9ed9fcfd98689c3bb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Besides Wall Street's top-and-bottom-line estimates for Danaher (DHR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.",
                "category": "company",
                "datetime": 1784207703,
                "headline": "Countdown to Danaher (DHR) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS"
              },
              {
                "id": 140909800,
                "url": "https://finnhub.io/api/news?id=fde23244a666d8526def31168d9334bb114a0cf4495c7890ac2d19b31790af39",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1784124016,
                "headline": "Earnings Preview: Icon PLC (ICLR) Q2 Earnings Expected to Decline"
              },
              {
                "id": 140903058,
                "url": "https://finnhub.io/api/news?id=1b9bb79e5447925160f2cf761525689933de4e75cf258ab6dbfb7d1244658cda",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "BOSTON & CHICAGO, July 14, 2026--Audax Private Equity and Linden Capital Partners Agree to Sell StatLab Medical Products to Leica Biosystems",
                "category": "company",
                "datetime": 1784064300,
                "headline": "Audax Private Equity and Linden Capital Partners Agree to Sell StatLab Medical Products to Leica Biosystems"
              },
              {
                "id": 140903059,
                "url": "https://finnhub.io/api/news?id=1e39d6420c0c67e38dbe2b616151d8ebdc6d16de155a5eb7a549963ffc19a939",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Leica Biosystems, an operating company of Danaher (the \"Company\"), and a global leader in anatomic pathology solutions advancing precision cancer diagnostics, announced today that the Company has entered into a definitive agreement to acquire privately held StatLab Medical Products (\"StatLab\"), a leading global developer and manufacturer of anatomical pathology products, from Linden Capital Partners and Audax Private Equity. Following the closing, StatLab will become part of Leica Biosystems.",
                "category": "company",
                "datetime": 1784061000,
                "headline": "Leica Biosystems to Acquire StatLab"
              },
              {
                "id": 140903060,
                "url": "https://finnhub.io/api/news?id=fe60382848891c7ac10f46b825b984ecef35e3651988b7720f1c114fb0b7de30",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Investors need to pay close attention to DHR stock based on the movements in the options market lately.",
                "category": "company",
                "datetime": 1784057940,
                "headline": "Implied Volatility Surging for Danaher Stock Options"
              },
              {
                "id": 140898283,
                "url": "https://finnhub.io/api/news?id=39537e6385a0d8bb861f77ea8b66cc195721e4d593c7fb9cbf265322e26f00f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1784037609,
                "headline": "Danaher (DHR) Reports Next Week: Wall Street Expects Earnings Growth"
              },
              {
                "id": 140885927,
                "url": "https://finnhub.io/api/news?id=476107059e36c9c3bd928f695f98309b2a569c0900ceea5cf136c1d6443a5d58",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "EMERYVILLE, Calif., July 13, 2026--OmniAb, Inc. (NASDAQ:OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, announces that it has appointed Amechi Nwachuku to the newly-created position of Executive Vice President and Chief Operating Officer, effective today. Mr. Nwachuku will be primarily responsible for managing the strategy, operations and commercial maximization of xPloration®, OmniAb’s proprietary, innovative high-throughp",
                "category": "company",
                "datetime": 1783944000,
                "headline": "OmniAb Names Amechi Nwachuku Chief Operating Officer"
              },
              {
                "id": 140884468,
                "url": "https://finnhub.io/api/news?id=45184e5757470f427e79bf23117b6bc48aeeeb57106b73f9cf57bdd78eae7f2e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "The cell isolation market is projected to grow from USD 4.39 billion in 2026 to USD 7.97 billion by 2031, with a CAGR of 12.7%. Key drivers include the expansion of cell and gene therapy, rising demand for immune cell isolation, and increased adoption of automated systems. Techniques like centrifugation, magnetic and fluorescence-activated cell sorting, and microfluidics enable enrichment of immune, stem, and tumor cells. The consumables segment is set to lead growth, propelled by the recurring",
                "category": "company",
                "datetime": 1783931460,
                "headline": "Cell Isolation Market/Cell Separation Market by Product, Cell Type, Source, Technique, Application, End User, Competition, Region - Global Forecast to 2031"
              },
              {
                "id": 140875597,
                "url": "https://finnhub.io/api/news?id=58dd51c165523cf6f8fdca73ce8120ffc91320b6d1f05d38c15fc981bb3749aa",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1359132436/image_1359132436.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DHR",
                "summary": "Mar Vista's U.S. Quality Premier strategy returned +10.15% net-of-fees in the second quarter of 2026. Read more here.",
                "category": "company",
                "datetime": 1783827720,
                "headline": "Mar Vista U.S. Quality Premier Portfolio Q2 2026 Portfolio Activity"
              },
              {
                "id": 140865222,
                "url": "https://finnhub.io/api/news?id=791ae73bf704bfbce3afcab86b035b2ad22dfe971fad0cee9e12627a57b6f74f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Abbott and Danaher both reported Q1 2026 results, but the businesses underneath those numbers point in opposite directions, and choosing the wrong one right now costs more than just a few percentage points of return.",
                "category": "company",
                "datetime": 1783707528,
                "headline": "Abbott Labs Vs. Danaher: Abbott’s Everyday Products Beat Danaher’s Slumping Biotech Equipment"
              },
              {
                "id": 140865989,
                "url": "https://finnhub.io/api/news?id=a2bb7068a7576da4a046247821b7c15e54246887626307f6b44f664fdee94d74",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2172795839/image_2172795839.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DHR",
                "summary": "Danaher stock analysis: Q1 results, bioprocessing growth, diagnostics weakness, and valuation vs. intrinsic value ($172.91). Click here to read more on DHR.",
                "category": "company",
                "datetime": 1783705485,
                "headline": "Danaher Is Getting Better, But The Stock Still Isn't Cheap"
              },
              {
                "id": 140861706,
                "url": "https://finnhub.io/api/news?id=66472b36404afa1792980621e16af98a26fb1e993b5fd7ba277342d1b73f2930",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher Corporation (NYSE:DHR) was among the stocks Jim Cramer discussed during Mad Money, as he called the growing wave of stock offerings and debt issuance a threat to the bull market. Expressing their wish to diversify, a caller inquired about the stock, and Cramer commented: Danaher’s been a huge disappointment, and we managed to get […]",
                "category": "company",
                "datetime": 1783684881,
                "headline": "Jim Cramer on Danaher: “I Don’t Want You Anywhere Near That One”"
              },
              {
                "id": 140862185,
                "url": "https://finnhub.io/api/news?id=f8bdbe29d024ca3200bbe0ad8788d4f26000e658dc3fc3853e4551ce1e85cf45",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/10/Kaufbeuren--Germany---May-2--2021-Qiagen.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "Private equity giants circle Qiagen (QGEN) with potential bids of $50/share. Get the details on the molecular diagnostics buyout.",
                "category": "company",
                "datetime": 1783675567,
                "headline": "Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover"
              },
              {
                "id": 140855851,
                "url": "https://finnhub.io/api/news?id=b78669addd9952e167ffd9d6b31c6133d81abcc3fe4ed720c2df88269166eb12",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Beckman Coulter Diagnostics, part of Danaher (DHR), has received CE Mark under IVDR for its Access p-Tau217 blood assay, drawing fresh attention to the stock’s diagnostics exposure and valuation. See our latest analysis for Danaher. Against this diagnostic milestone, Danaher’s share price has softened this year. The stock is at $190.77 with a year to date share price return down 17.2%, while the 1 year total shareholder return is down 4.37%. This suggests sentiment has cooled despite interest...",
                "category": "company",
                "datetime": 1783631754,
                "headline": "Danaher (DHR) Wins CE Mark For Access P Tau217 Assay, Is The Stock A Bargain?"
              },
              {
                "id": 140853716,
                "url": "https://finnhub.io/api/news?id=695956b2ab65d68b2b3f676f04a52105e2ab3b5e4a376e3960caa4fd0dc70c9b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "VTRS vs. DHR: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1783611604,
                "headline": "VTRS or DHR: Which Is the Better Value Stock Right Now?"
              },
              {
                "id": 140851723,
                "url": "https://finnhub.io/api/news?id=adab0e54b2cd05edff59575e88d1eecd33a73d0980c3a0ffdfab4fcc4e7eb226",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1442797246/image_1442797246.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DHR",
                "summary": "Illumina dominates genomics sequencing with recurring growth, NovaSeq X catalysts, and improving margins/FCF. Click to know why the ILMN shares look promising.",
                "category": "company",
                "datetime": 1783595255,
                "headline": "Illumina: While You Chased AI, This Healthcare Stock Built A $30B Moat"
              },
              {
                "id": 140849347,
                "url": "https://finnhub.io/api/news?id=d244267842f3e29e0839f9937e0151192287b6a3300b43ce4bdf512a222f1bda",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.",
                "category": "company",
                "datetime": 1783590540,
                "headline": "1 Cash-Producing Stock with Competitive Advantages and 2 We Brush Off"
              },
              {
                "id": 140843493,
                "url": "https://finnhub.io/api/news?id=6965288a4937947801c099381791136a3fc20a3c219a24c1ece262f5eee177a5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher's Biotechnology segment posts 7% core revenue growth as bioprocessing demand strengthened, even as weaker product demand created headwinds.",
                "category": "company",
                "datetime": 1783525800,
                "headline": "Will Strength in Biotechnology Unit Continue to Drive DHR's Growth?"
              },
              {
                "id": 140845008,
                "url": "https://finnhub.io/api/news?id=4a277941766a5de0378493dafe626ec2f71fa68672a90db59eec27da35febbda",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders will",
                "category": "company",
                "datetime": 1783517708,
                "headline": "9 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 140831580,
                "url": "https://finnhub.io/api/news?id=879c25f895af976f7a3758247d6e089b7069e8809338515280184e9028298a58",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Tap these five stocks, W, DHR, ISRG, BEAT and CSW, with rising P/E ratios to try out an out-of-the-box approach.",
                "category": "company",
                "datetime": 1783430760,
                "headline": "Bet On These 5 Top-Ranked Stocks With Increasing P/E Ratios"
              },
              {
                "id": 140827764,
                "url": "https://finnhub.io/api/news?id=4a036a29e28f8e7e681b302b197a3995519ab166928930648d83ce16b202cb4b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Beckman Coulter Diagnostics, a global leader in clinical diagnostics and a Danaher company, today announced it received CE Mark under IVDR for its Access p-Tau217 assay, a blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of cognitive decline. The company also introduced its high-specificity Access BD-pTau217 Research Use Only (RUO) assay at the Alzheimer's Association International Conference (AAIC) 2026 in London.",
                "category": "company",
                "datetime": 1783407600,
                "headline": "Beckman Coulter Diagnostics Expands Alzheimer's Portfolio with CE-Marked p-Tau217 Blood Test and New High-Specificity Research Assay"
              },
              {
                "id": 140822681,
                "url": "https://finnhub.io/api/news?id=22a6ea77688d8c8b105dd77cc1ff48d0bd4bf9db171a72f5b2c5ffc98f879259",
                "image": "",
                "source": "Benzinga",
                "related": "DHR",
                "summary": "Evercore ISI Group  analyst Vijay Kumar   maintains Danaher (NYSE:DHR) with a Outperform and lowers the price target from $232 to $230.",
                "category": "company",
                "datetime": 1783339708,
                "headline": "Evercore ISI Group Maintains Outperform on Danaher, Lowers Price Target to $230"
              },
              {
                "id": 140801152,
                "url": "https://finnhub.io/api/news?id=5102acf48264aad2443d7f7b7a501fd11da8b3cc4d6f7ce2c7464ec49961bcdc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher will release its second-quarter earnings later this month, and analysts anticipate a low single-digit bottom-line growth.",
                "category": "company",
                "datetime": 1783076083,
                "headline": "What to Expect From Danaher's Next Quarterly Earnings Report"
              },
              {
                "id": 140761657,
                "url": "https://finnhub.io/api/news?id=c083ffa01e134543722c1abb0d77239bd81b20a0bf56cb1c584d4d1e39ce65f0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "The Danaher Foundation, supported by Danaher Corporation (NYSE: DHR), today announced a $1 million commitment to support urgent, on-the-ground response to the Ebola Bundibugyo outbreak in the Democratic Republic of Congo (DRC) and Uganda through Save the Children, the International Rescue Committee (IRC) and the World Food Program USA in support of the World Food Programme (WFP).",
                "category": "company",
                "datetime": 1782736200,
                "headline": "Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa"
              },
              {
                "id": 140760377,
                "url": "https://finnhub.io/api/news?id=346aaa178a9d6d68eb59e178bd3d354cbd601a116988c339acee1699ac6959b9",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1210929707/image_1210929707.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DHR",
                "summary": "Danaher (DHR) is a high-quality life sciences holding company, but current valuation does not justify a buy.",
                "category": "company",
                "datetime": 1782713054,
                "headline": "Danaher: Why I'm Not Paying 24x P/E For 8% EPS Growth"
              },
              {
                "id": 140759241,
                "url": "https://finnhub.io/api/news?id=b602e614b8580e2d1ec5496977143b7a973740f07448a6606ae6e9f4d71bd55f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DHR",
                "summary": "Danaher Corporation (NYSE:DHR) is one of the best long term stocks to buy according to hedge funds. On June 10, Danaher completed its acquisition of Masimo Corporation, a specialist in pulse oximetry and patient monitoring solutions. Masimo will now function as a standalone operating company within Danaher’s Diagnostics segment, retaining its original brand identity while […]",
                "category": "company",
                "datetime": 1782710880,
                "headline": "Danaher (DHR) Completes $9.9B Acquisition of Masimo Corporation"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 5,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.5,
            "source_article_count": 113,
            "discarded_article_count": 90
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 19.5,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 0.9,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50；升放量(近10日2日)；Ready=N；Confirm=Y",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 5589566.666666667,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 8679060,
              "avg_vol_20": 6108700,
              "avg_vol_30": 5589566.666666667,
              "range_pct_10": 0.20517457615913728,
              "range_pct_20": 0.20517457615913728,
              "range_pct_30": 0.20517457615913728,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.5527250174432126,
              "dist_to_20d_high": 0.03649739580812236,
              "down_shrink_days": 1,
              "breakout_level_20d": 206.59,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 1
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.8,
          "rsiKdjPoints": 4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.4,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.5,
            "details": {
              "atrPct": 4.190956982803964,
              "turnoverUsdM": 1863.803707840485,
              "liquidityPoints": 0.8,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.DHR",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 182.3658,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 8.4,
            "take_profit_price": 216.2208,
            "target_multiplier": 1.9,
            "technical_strength": 1.63,
            "take_profit_percent": 8.6
          },
          "positionPoints": 1.5,
          "stopLossPoints": 1.2,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 8.381913965607929,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 100,
    "atr": {
      "atr": 8.3421,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 4.19
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "強勢區",
      "score": 10,
      "value": 94.43
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "強累積",
      "score": 10,
      "value": 0.3567
    },
    "kdj": {
      "d": 65.09,
      "j": 74.6,
      "k": 68.26,
      "rule": "Cursor_18.24 K/D cross",
      "score": 6,
      "signal": "強金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 65.03
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 4,
      "trend": "弱勢",
      "value": 30453995,
      "recentSlope": -473510.5,
      "previousSlope": 1433780
    },
    "rsi": 56.42,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 202.6661,
      "position": "SAR喺價上",
      "distancePct": 1.82,
      "previousTrend": "下降"
    },
    "ma50": 185.7788,
    "macd": {
      "macd": 2.0372579710158334,
      "trend": "中性偏多",
      "signal": 2.777397645113497,
      "histogram": -0.7401396740976636
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 8,
      "value": 190.1877,
      "position": "連續3日>VWAP",
      "consecutiveAbove": 4
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.46,
      "score": 6,
      "avgVolume": 6400750,
      "currentVolume": 9363495
    },
    "derived": {
      "ma20": 195.1695,
      "ma50": 185.7788,
      "prevClose": 196.5,
      "avgVolume10": 9196560,
      "avgVolume20": 6400750,
      "changePercent": 1.3,
      "avgVolumeForScore": 6400750
    },
    "ma_cross": {
      "ma20": 195.1695,
      "ma50": 185.7788,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 194.856,
      "prevMa50": 185.0886,
      "spreadPct": 5.05,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 181.7209,
      "upper": 208.6181,
      "position": "上半部"
    },
    "rsi_short": 47.67,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.46
    }
  }
}

{
  "close": 199.05,
  "volume": 9363495,
  "changePercent": 1.3
}